Changes to the Code
S. 3716 · RARE Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
21 U.S.C. § 360cc Protection for drugs for rare diseases or conditions
5 changes the bill asks for here, 1 carried out
- Not carried out:
in subsection (a), in the matter following paragraph (2), by striking
same disease or condition
and insertingsame approved use or indication within such rare disease or condition
;“same disease or condition” isn't in § 360cc(a) in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“same disease or condition” not found in /us/usc/t21/s360cc/a - Not carried out:
in the matter preceding paragraph (1), by striking
same rare disease or condition
and insertingsame approved use or indication for which such 7-year period applies to such already approved or licensed drug
; and“same rare disease or condition” isn't in § 360cc(b) in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“same rare disease or condition” not found in /us/usc/t21/s360cc/b - Not carried out:
in paragraph (1), by inserting
, relating to the approved use or indication,
afterthe needs
;The law already reads this way: § 360cc(b)(1) already has “, relating to the approved use or indication,”.
Technical detail
already reads “, relating to the approved use or indication,” at that place in /us/usc/t21/s360cc/b/1 - Not carried out:
in subsection (c)(1), by striking
same rare disease or condition as the already approved drug
and insertingsame use or indication for which the already approved or licensed drug was approved or licensed
; and“same rare disease or condition as the already approved drug” isn't in § 360cc(c)(1) in the Code as we have it. The law may have changed since the bill was drafted.
Technical detail
“same rare disease or condition as the already approved drug” not found in /us/usc/t21/s360cc/c/1 - Carried out:
by adding at the end the following:
(f) Approved use or indication defined.— In this section, the term “approved use or indication” means the use or indication approved under section 505 of this Act or licensed under section 351 of the Public Health Service Act for a drug designated under section 526 for a rare disease or condition..
The section already has a provision under this letter or number, so it would have two.
This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.
1 of the 5 changes this bill asks for here is already in the law as it stands, and was not made a second time. The bill, or another making the same changes, has probably become law since.
§ 360cc(e)–(f)
Start of § 360cc to (e)(1) unchanged
| Where | Mark | The Code now | Mark | As the bill would leave it |
|---|---|---|---|---|
| (e)(2) | (2) | (2) | ||
| upon granting exclusive approval or licensure under subsection (a) on the basis of a demonstration of clinical superiority as described in subsection (c), shall publish a summary of the clinical superiority findings. | upon granting exclusive approval or licensure under subsection (a) on the basis of a demonstration of clinical superiority as described in subsection (c), shall publish a summary of the clinical superiority findings. | |||
| (f) | (f) Approved use or indication defined | (f) Approved use or indication defined | ||
| In this section, the term “approved use or indication” means the use or indication approved under section 355 of this title or licensed under section 262 of title 42 for a drug designated under section 360bb of this title for a rare disease or condition. | In this section, the term “approved use or indication” means the use or indication approved under section 355 of this title or licensed under section 262 of title 42 for a drug designated under section 360bb of this title for a rare disease or condition. | |||
| (f) | (f) [inserted: Approved use or indication defined.—] | |||
| [inserted: In this section, the term “approved use or indication” means the use or indication approved under section 505 of this Act or licensed under section 351 of the Public Health Service Act for a drug designated under section 526 for a rare disease or condition.] | ||||